LONDON, Dec. 2, 2022 /PRNewswire/ The Global Cancer Gene Therapy Market is expected to amass a valuation of USD 4047.8 billion by 2028 from USD 2058.7 billion in 2021. It is expected to expand
/PRNewswire/ The Global Cancer Gene Therapy Market is expected to amass a valuation of USD 4047.8 billion by 2028 from USD 2058.7 billion in 2021. It is.
World Cancer Gene Therapy Market Industry Forecasts to 2030
News provided by
Share this article
Share this article
ResearchAndMarkets.com s offering.
The Global Cancer Gene Therapy Market was valued at USD 558.24 million in 2019 and is estimated to reach USD 16.50 billion by 2030, expanding at a CAGR of 32.6% during the forecast period, from 2020 to 2030
Gene therapy is a method of replacing or inactivating the mutated genes responsible for causing diseases or the genes that affect the proper functioning of organs, by introducing a new gene into the body. The adoption of cancer gene therapy is rising due to its high success rate achieved during trials. Cancer gene therapy is used as a substitute of the conventional drugs and surgeries to treat cancer. It has several advantages including high efficacy, minimum side effects and speedy recovery.